Diet‑related factors in Sjögren’s syndrome and their implications for dietary guidance: a scoping review
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Sjögren’s syndrome (SS) is a chronic systemic autoimmune disease characterised by immune‑mediated damage to exocrine glands, particularly the salivary and tear‑producing glands, leading to dry mouth (xerostomia) and dry eyes (xerophthalmia).1 Beyond glandular involvement, SS is associated with ongoing immune activation and lymphocytic infiltration, which can result in a range of extra‑glandular manifestations. These may include joint pain, interstitial lung disease, gastrointestinal, hepatic, pancreatic, renal, haematological and gynaecological involvement, as well as cardiovascular complications such as accelerated atherosclerosis. 1-3 The most serious complication of SS is the development of non‑Hodgkin’s lymphoma. 4 Sjögren’s syndrome is classified as either primary SS (pSS), occurring as an isolated autoimmune condition, or secondary SS (sSS), when it presents in association with other autoimmune rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, or dermatomyositis. 2,3 Sjögren’s syndrome predominantly affects women, with peak prevalence observed in those aged 50–59 years, accounting for approximately 24% of global cases. 5 Increased prevalence in postmenopausal women is thought to reflect hormonal and immune‑related changes, including declining oestrogen and androgen levels, which may impair glandular function and contribute to systemic inflammation.6 The systemic nature of SS has significant implications for nutritional status and dietary management. Up to 80% of individuals with SS experience dysphagia, likely due to xerostomia and oesophageal dysmotility, negatively affecting dietary intake and quality of life.7 Gastrointestinal symptoms are reported by up to 95% of patients and include gastroesophageal reflux, dyspepsia and chronic constipation, potentially arising from autonomic dysfunction, immune‑mediated pancreatic or hepatic involvement and reduced salivary flow. 7-9 These symptoms may impair digestion and absorption of key nutrients, further increasing nutritional risk. Fatigue affects more than 80% of individuals with SS and is associated with reduced functional capacity, impaired activities of daily living, and poorer health‑related quality of life. 7,10 When combined with dysphagia and gastrointestinal symptoms, fatigue may further increase the risk of malnutrition. Cardiovascular disease is an increasingly recognised complication of SS, with chronic inflammation thought to contribute to endothelial dysfunction, arterial stiffness and atherosclerosis. 11 A recent systematic review and meta‑analysis demonstrated an association between pSS and early markers of cardiovascular disease, highlighting the potential role of modifiable lifestyle factors, including diet, in risk reduction. 11 Despite these substantial nutrition related challenges, there are currently no condition specific dietary guidelines for individuals with SS. In the absence of formal guidance, dietitians play a critical role in providing individualised, evidence informed dietary advice to support symptom management, nutritional adequacy and long term chronic disease risk reduction. However, the extent and nature of the available evidence underpinning such dietary guidance remain unclear, highlighting the need for a systematic examination of the existing literature. Emerging evidence suggests that specific dietary patterns and supplements may offer therapeutic benefit in SS. Greater adherence to a Mediterranean dietary pattern has been associated with lower disease activity, reduced prevalence of hypertension, and decreased use of immunosuppressive medications. 12 In addition, omega 3 fatty acid supplementation (2 × 1000 mg/day) over an eight week period has demonstrated improvements in ocular symptoms and salivary flow compared with placebo in a randomised controlled trial. 13 While these findings are promising, the evidence base is limited by small sample sizes and heterogeneity in study design. Collectively, this underscores the need to systematically map the literature to clarify how existing evidence may inform dietary guidance for individuals with SS. The aim of this scoping review is to map the existing literature describing dietary patterns, food groups, nutrients and supplements that have been examined in individuals with primary or secondary Sjögren’s syndrome, and to explore how this evidence may inform dietary recommendations. This scoping review seeks to characterise the nature and extent of the literature, clarify how current evidence may inform dietary advice, and identify gaps in knowledge to guide future research and support nutrition professionals in evidence‑informed practice.
Fields of Study & Subjects
Salivary Gland Disorders and Functions
Ocular Surface and Contact Lens
Systemic Lupus Erythematosus Research
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint